Related Experiment Video
Updated: Aug 12, 2025

In Vitro Drug Screening Against All Life Cycle Stages of Trypanosoma cruzi Using Parasites Expressing β-galactosidase
Published on: November 5, 2021
Tolerance and Adherence of Patients with Chronic Chagas Disease Treated with Benznidazole
Cristina Vázquez1, Elisa García-Vázquez1,2, Bartolomé Carrilero1
1Hospital Clínico Universitario Virgen de la Arrixaca, Microbiology Service, El Palmar, Murcia, Spain.
Background:
Chagas disease (CD) treatment is commonly associated with a high incidence of adverse effects. It is crucial to study and update these adverse effects to improve the existing knowledge of which drugs to use and to clarify the information presented to patients.
Methods:
We analyzed the adverse effects of benznidazole in two cohorts of patients: a large retrospective study and a small prospective study.
Results:
This large retrospective study described the most and least common adverse effects in our area and characterized our Chagas disease population. This prospective study, along with a close follow-up of the treatment, detected more adverse effects and enhanced the patients' perception of the disease and treatment.
Conclusions:
This information is important for preventing non-medical-related withdrawals and for removing baseless fears. Better knowledge of patients could help us provide better care.
Related Concept Videos
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Chronic Pancreatitis II: Collaborative Care
Assessment:
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Desensitization and Tachyphylaxis
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Drug Therapy
Antianxiety Medications

